SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001447028-20-000046
Filing Date
2020-05-11
Accepted
2020-05-11 08:29:26
Documents
3
Period of Report
2020-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2020-q1earningsrelease8xk.htm 8-K 29125
2 EXHIBIT 99.1 a2020-q1earningsreleaseex9.htm EX-99.1 128669
3 arbutuslogoa01.jpg GRAPHIC 15988
  Complete submission text file 0001447028-20-000046.txt   181224
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 20862741
SIC: 2834 Pharmaceutical Preparations